Restoring funding for basic biomedical research appears to have lost favor with policymakers, because it does not offer immediate self-sustaining economic returns. And funding for basic research remains a low priority in emerging economies like China, where it accounts for less than 15 cents for every research dollar spent (compared to 35 cents in the US).